Skip Navigation

European Heart Journal 2000 21(7):590-591; doi:10.1053/euhj.2000.1934
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Faber, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faber, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editor

Acute and long-term results after TASH

L. Faber

Heart Center NRW, Bad Oeynhausen, Germany

References

  1. Gietzen FH, Leuner CJ, Raute-Kreinsen U. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH): catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J. 1999;20:1342–1354[Abstract/Free Full Text]
  2. Faber L, Seggewiss H, Strick S, Bogunovic N, Gleichmann U. Intra-procedural myocardial contrast echocardiography: A routine procedure in PTSMA for HOCM. Eur Heart J. 1998;19:12[ISI][Medline]
  3. Maron BJ. New interventions for obstructive HCM: Promise and prudence. Eur Heart J. 1999;20:1292–1293[Free Full Text]
  4. Faber L, Seggewiss H, Fassbender D, Strick S, Schmidt HK, Gleichmann U. Risk factors for permanent trifascicular block after PTSMA in HOCM. Circulation. 1997;96:I-645
  5. Faber L, Seggewiss H, Fassbender D, Strick S, Schmidt HK, Gleichmann U. Identification of patients requiring DDD-pacemaker after PTSMA for HOCM. J Am Coll Cardiol. 1998;31:27A
  6. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy: acute results and 30-month follow-up in 25 patients. J Am Coll Cardiol. 1998;31:252–258[Abstract/Free Full Text]
  7. Faber L, Seggewiss H, Fassbender D. Perkutane transluminale septale Myokardablation: Akutergebnisse bei 66 Patienten unter Berücksichtigung der Myokard-Kontrastechokardiographie. Z Kardiol. 1998;87:191–197[CrossRef][ISI][Medline]
  8. Faber L, Seggewiss H, Fassbender D, Strick S, Gleichmann U. Guiding of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy by myocardial contrast echocardiography. J Interven Cardiol. 1998;11:443–448[CrossRef][ISI]
  9. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy: Results with respect to intra-procedural myocardial contrast echocardiography. Circulation. 1998;98:2415–2421[Abstract/Free Full Text]
  10. Gleichmann U, Seggewiß H. Klinik und Therapie der hypertrophen Kardiomyopathie. Med Klinik. 1998;93:260–267
  11. Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradients in hypertrophic obstructive cardiomyopathy. Circulation. 1998;97:461–466[Abstract/Free Full Text]
  12. Klues HG, Proschan MA, Dollar AL, Spirito P, Roberts WC, Maron BJ. Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy: Anatomic validation from mitral valve specimen. Circulation. 1993;88:548–555[Abstract/Free Full Text]
  13. Faber L, Seggewiss H, Gleichmann U. Intra-procedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area. Cathet Cardiovasc Intervent. 1999;47:462–466[CrossRef][ISI][Medline]
  14. Faber L, Seggewiss H, Ziemssen P, Gleichmann U. Percutaneous transluminal septal myocardial ablation in HOCM: Intra-procedural myocardial contrast echocardiography as a routine procedure. J Am Coll Cardiol. 1999;33:501A

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HeartHome page
F H Gietzen, C J Leuner, L Obergassel, C Strunk-Mueller, and H Kuhn
Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients
Heart, June 1, 2004; 90(6): 638 - 644.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
F. H. Gietzen, C. J. Leuner, L. Obergassel, C. Strunk-Mueller, and H. Kuhn
Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions
Circulation, July 23, 2002; 106(4): 454 - 459.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Faber, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faber, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?